40 Years of CSF Toxicity Studies in ALS: What Have We Learnt About ALS Pathophysiology?
Title | 40 Years of CSF Toxicity Studies in ALS: What Have We Learnt About ALS Pathophysiology? |
Publication Type | Journal Article |
Year of Publication | 2021 |
Authors | Kwong KChong Ng K, Harbham PK, Selvaraj BT, Gregory JM, Pal S, Hardingham GE, Chandran S, Mehta AR |
Journal | Front Mol Neurosci |
Volume | 14 |
Pagination | 647895 |
Date Published | 2021 |
ISSN | 1662-5099 |
Abstract | Based on early evidence of neurotoxicity following exposure to serum derived from patients with amyotrophic lateral sclerosis (ALS), several studies have attempted to explore whether cerebrospinal fluid (CSF) obtained from people with ALS could possess similar properties. Although initial findings proved inconclusive, it is now increasingly recognized that ALS-CSF may exert toxicity both and . Nevertheless, the mechanism underlying CSF-induced neurodegeneration remains unclear. This review aims to summarize the 40-year long history of CSF toxicity studies in ALS, while discussing the various mechanisms that have been proposed, including glutamate excitotoxicity, proteotoxicity and oxidative stress. Furthermore, we consider the potential implications of a toxic CSF circulatory system in the pathophysiology of ALS, and also assess its significance in the context of current ALS research. |
DOI | 10.3389/fnmol.2021.647895 |
Alternate Journal | Front Mol Neurosci |
PubMed ID | 33815058 |
PubMed Central ID | PMC8012723 |
Grant List | MEHTA/JUL17/948-795 / MNDA_ / Motor Neurone Disease Association / United Kingdom MR/L023784/2 / MRC_ / Medical Research Council / United Kingdom MR/R001162/1 / MRC_ / Medical Research Council / United Kingdom |